Clinical features, etiology and treatment of facial dyskinesias in the elderly.
D000367:Age Factors; D000368:Aged; D001921:Brain / Q000378:metabolism; D001925:Brain Damage, Chronic / Q000150:complications; D001933:Brain Stem; D002819:Chorea / Q000150:complications / Q000188:drug therapy; D003704:Dementia / Q000150:complications; D004298:Dopamine / Q000378:metabolism; D005145:Face; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications; D007980:Levodopa / Q000009:adverse effects; D008046:Lip; D008297:Male; D009069:Movement Disorders / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology*; D010277:Parasympathomimetics / Q000378:metabolism; D010300:Parkinson Disease / Q000150:complications; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use; D014059:Tongue
D010277:Parasympathomimetics; D010640:Phenothiazines; D007980:Levodopa; D006220:Haloperidol; D004298:Dopamine